South African vaccine manufacturer Biovac has secured a further $20m (R327m) from two French development finance institutions. This brings its total fundraising to $128m (R2.4bn) and leaves the company within striking distance of its $180m (R2.95bn) target. Moreover, this new investment marks a significant milestone in the ongoing Biovac expansion fundraising effort. Agence Française de Développement and its private-sector arm,…
Tag: Gavi
-
African Vaccine Manufacturing Expansion Set For Biovac Site
The South African vaccine producer Biovac has announced a major expansion of its Cape Town operations. This is a significant development in African vaccine manufacturing. This ambitious project receives significant backing from the European Investment Bank (EIB) Group and the International Finance Corporation (IFC). The new financing package will help Biovac develop end-to-end production capabilities. The primary focus will initially…
-
Malaria Financing In Africa: Strategies and Solutions
As African leaders met in Addis Ababa for the 39th AU Summit, malaria was back in the spotlight. Malaria Financing In Africa is now more urgent as new data indicate that the disease is increasing again after years of progress. That reversal is colliding with shrinking donor support and harsher climate conditions. The World Health Organisation (WHO) estimates that 610,000…
-
Children’s Lives at Risk as US Proposes Slashing Funds for Gavi
In a move putting children’s lives at risk, the US government has announced its intention to cut funding for Gavi, the Vaccine Alliance. It is a key organisation credited with saving millions of lives through childhood immunisation. The decision comes at a critical time, as rising vaccine hesitancy contributes to a resurgence of preventable diseases like measles worldwide. The proposed…
-
Vaccine Campaigns Under Threat from Misinformation
A new wave of vaccine misinformation, led by US Secretary of Health & Human Services Robert F Kennedy Jr, is threatening to undermine global public health. South African experts are warning of dire consequences. His recent social media attack on Gavi, the international vaccine alliance, and the widely used DTP (diphtheria, tetanus, and pertussis) vaccine overlooks decades of scientific evidence.…
-
Emergency Vaccinations Reduce Global Disease Deaths
New research has revealed the immense power of emergency vaccination programmes. These programmes have reduced deaths from five major infectious diseases by an estimated 60% over the past two decades. The study, the first of its kind, also highlights the colossal economic benefits of rapid vaccine deployment. Researchers estimate these benefits at tens of billions of dollars. Researchers analysed the…
-
Biovac Secures Deal to Produce Pneumonia Vaccine
In a significant move for continental health security, Cape Town-based research group Biovac has announced a major technology transfer agreement with Indian pharmaceutical firm Biological E. The Biovac initiative will enable the company to produce and distribute a pneumococcal conjugate vaccine (PCV14) across Africa. This marks a vital step towards self-sufficiency in vaccine manufacturing. The partnership will accelerate the growth…
-
Child Mortality Crisis and the Gates Foundation’s Pledge
The Bill & Melinda Gates Foundation has announced it will commit $1.6 billion over the next five years. This funding aims to support Gavi, the Vaccine Alliance, in its mission to immunise the world’s most vulnerable children. The initiative addresses the ongoing child mortality crisis. The pledge comes ahead of a crucial fundraising event in Brussels. It is positioned as…
-
Global Health Giants Consider Merger Amidst Funding Crunch
In a significant development for global health, two of the world’s leading organisations, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Gavi vaccine alliance, are in discussions to merge some operational functions. This strategic move aims to combat a severe financing crunch. A Response to Aid Budget Pull-Backs While discussions about more efficient collaboration have been ongoing…
-
Trump administration cuts $2.6bn in vaccine funding
The Trump administration’s announcement to reduce US foreign aid funding has sent shockwaves through the global health community. Among the most affected are Gavi, the Vaccine Alliance, and major anti-malaria initiatives. These cuts, part of a broad reduction in programmes managed by the United States Agency for International Development (USAID), have raised significant concerns regarding the future of life-saving interventions…